Sign in

CIK 0001356090 · Non-accelerated filer<br>Smaller reporting company

PRECIGEN, INC.

Sign in to watch
Ticker
PGEN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
VA
Entity type
operating
Phone
301-556-9900
Business address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
Former names
INTREXON CORP
  1. 4 Open-market buy Director bought 96,686 shares at $1.41 ($136,327)
  2. 4 Open-market sale Director sold 96,686 shares at $1.41 ($136,327)
  3. S-3 Offering Registration Statement
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 4 Open-market buy Director bought 25,000 shares at $1.41 ($35,250)
  7. 4 Planned sale President and CEO sold 76,969 shares at $1.53 ($117,763)
  8. 4 Planned sale Chief Legal Officer sold 10,947 shares at $1.64 ($17,953)
  9. 4 Planned sale Chief Operating Officer sold 5,388 shares at $1.64 ($8,836)
  10. 4 Planned sale SVP, IP Affairs sold 8,891 shares at $1.64 ($14,581)
  11. 4 Planned sale Chief Financial Officer sold 9,045 shares at $1.64 ($14,834)
  12. 4 Planned sale SVP, IP Affairs sold 8,741 shares at $1.55 ($13,549)
  13. 4 Planned sale Chief Financial Officer sold 8,893 shares at $1.55 ($13,784)
  14. 4 Planned sale Chief Legal Officer sold 10,762 shares at $1.55 ($16,681)
  15. 4 Planned sale Chief Operating Officer sold 5,298 shares at $1.55 ($8,212)
  16. 4 Planned sale President and CEO sold 55,855 shares at $1.66 ($92,719)
  17. 4 Insider Changes in Ownership
  18. 4 Open-market buy Director bought 500,000 shares at an average $1.52 ($757,612)
  19. 4 Open-market buy Director bought 570,345 shares at $1.75 ($998,104)
  20. 4 Open-market buy Director bought 400,000 shares at $1.72 ($688,000)

Page 13 of 67 · 1,325 filings